ESC/ERS low-risk profile achievement accurately predicts mortality in scleroderma-associated PAH

Conclusions: Our findings suggest that an abbreviated version of guidelines’ risk assessment accurately predicts SScPAH mortality. Achievement of low-risk profile is associated with better outcome and could represent a valid surrogate endpoint for clinical trials in SScPAH.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Pulmonary hypertension Source Type: research